【24h】

Preface

机译:前言

获取原文

摘要

The 62nd Annual Meeting of The Japanese Society for Dialysis Therapy, held in June 2017 in Yokohama, Japan, brought together 22,412 participants from Japan and overseas for special lectures, educational lectures, symposia, and workshops to discuss the theme "Time for Transformation: A Bright Future for Dialysis Thera-py." As a result of the statistical survey at the end of 2016, The Overview of Regular Dialysis, 329,609 patients were under dialysis, an increase of 4,623 patients compared to end of 2015. This number is the third largest number in the world next to the United States and China. However, the number of peritoneal dialysis (PD) patients was only 9,021, 2.7% of all dialysis patients. The number of PD patients has been declining since 1998. More than 95% of these patients undergo in-center hemodialysis (HD), and very few ESRD patients undergo PD and kidney transplantation. This in-center excessive bias of HD is a feature of dialysis therapy in Japan. Another important issue facing Japan is the aging of dialysis patients. The average age of patients introduced to dialysis in 2016 was 69.4 years, respectively, rising by 0.2 years from 2015. The average age of males was 68.57 years, and that of females was 71.19 years, an increase of 0.20 and 0.24 years, respectively, as compared with 2015. The average age of maintenance dialysis patients was 68.15 years, which increased by 0.29 years compared with the previous year. The average age of males was 67.34 years, an increase of 0.27 years; the average age of females was 69.61 years, an increase of 0.33 years. Both males and females, 65-69 years old, represented the highest proportions. This increase in average age is largely due to the aging population. In addition, the effect of treatment of renal failure patients in the preservation period is good in Japan. The rapid increase in the number of dialysis patients does not only concern Japan. It is a major global problem in the world including Asia, Africa, Europe, and America.
机译:2017年6月在日本横滨举行的日本透析治疗年会第62次会议,汇集了来自日本和海外的22,412名与会者,以进行特别讲座,教育讲座,专题讨论会和研讨会,讨论主题“转型时间:a透析的光明未来Thera-py。“由于2016年底的统计调查,常规透析综述,329,609名患者在透析下,与2015年底相比,4,623名患者。这个数字是联合国旁边世界第三大数字国家和中国。然而,腹膜透析(PD)患者的数量仅为9,021,所有透析患者的2.7%。自1998年以来,PD患者的数量一直在下降。超过95%的这些患者接受中心血液透析(HD),并且非常少数ESRD患者接受PD和肾移植。这种中心过多的HD偏差是日本透析治疗的特征。日本面临的另一个重要问题是透析患者的老化。 2016年透析为透析的患者的平均年龄分别为69.4岁,从2015年起增加0.2岁。男性的平均年龄为68.57岁,女性为71.19岁,分别增加0.20%和0.24岁,分别增加0.20%和0.24岁,与2015年相比。维持透析患者的平均年龄为68.15岁,与去年相比增加了0.29岁。男性的平均年龄为67.34岁,同比增长0.27岁;女性的平均年龄为69.61岁,同比增长0.33岁。 65-69岁的男性和女性,代表最高的比例。平均年龄的增加主要是由于人口老龄化。此外,在保存期间治疗肾功能衰竭患者的影响在日本良好。透析患者数量的快速增加不仅关注日本。这是世界上的一个主要的全球问题,包括亚洲,非洲,欧洲和美国。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号